Indication

Target/marker/pathway

Summary

Licensing status

Publication and contact information

Infectious disease

Infectious disease

Mucin 5B oligomeric mucus/gel-forming (MUC5B)

Mouse studies suggest maintaining baseline MUC5B expression is necessary to promote the clearance of pathogens from respiratory surfaces. Excessive mucus is associated with multiple respiratory diseases, but the consequences of inhibiting mucus production are unknown. In mice, deletion of Muc5b, which encodes a glycoprotein component of airway mucus, decreased mucociliary clearance, mucus transport, growth and survival compared with no alteration. In the mutant mice, antibiotics reversed lethality, indicating that death resulted from infection rather than airway obstruction. Next steps include developing therapeutics that target the cysteine-rich regions that link MUC5B molecules into chains and understanding how mucins interact with immune cells.

SciBX 7(2); doi:10.1038/scibx.2014.58
Published online Jan. 16, 2014

Unpatented; licensing status not applicable

Roy, M.G. et al. Nature; published online Dec. 8, 2013;
doi:10.1038/nature12807
Contact: Christopher M. Evans, University of Colorado Denver School of Medicine, Aurora, Colo.
e-mail:
christopher.evans@ucdenver.edu